Advertisement

Pediatric Cardiology

, Volume 40, Issue 1, pp 23–28 | Cite as

Eisenmenger Syndrome in Adults: Treatment Pattern and Prognostic Factors in the Advanced Pulmonary Vasodilator Era

  • Hyo Soon An
  • Gi Beom KimEmail author
  • Mi Kyoung Song
  • Ji Seok Bang
  • Sang Yun Lee
  • Eun Jung Bae
  • Chung Il Noh
Original Article

Abstract

Patients with Eisenmenger syndrome (ES) have a higher mortality rate than patients with simple congenital heart disease (CHD). To determine factors associated with death in the era of advanced pulmonary vasodilator treatment, we analyzed the characteristics of adult ES patients depending on underlying CHD. Simple septal defects and patent ductus arteriosus were classified as simple CHD, and other conditions were classified as complex CHD. Sixty-seven adult ES patients (50.7% women) were reviewed retrospectively. CHD was diagnosed at a median of 10.0 years of age and ES was diagnosed at 18.6 years. Thirteen patients (19.4%) died; the median age was 38.6 years (IQR 32.2–47.8). In a multivariate analysis, patients with SpO2 < 85% had a higher mortality rate than others [hazard ratio (HR) 9.7; 95% confidence interval (CI) 1.002–95.2, p = 0.05]. In simple CHD patients, those with a low platelet count (< 100 × 109/L) or low SpO2 (< 85%) were at a higher risk of death than those without (HR 16.32, 95% CI 1.25–2266.31, p = 0.032; and HR 38.91, 95% CI 3.44–5219.41, p = 0.001, respectively). Advanced pulmonary vasodilators were used more in survivors than in non-survivors (48.1% vs. 15.4%, p = 0.032). Low SpO2 and platelet count were related to mortality in adult ES, especially in those with simple CHD. Therefore, careful attention should be paid to the care of adult ES patients with this tendency; active pulmonary vasodilator treatment should be considered.

Keywords

Eisenmenger syndrome Congenital heart disease Adult Platelet counts 

Notes

Acknowledgements

We are grateful to Prof. So-hee Oh, Department of Statistics at the Seoul Metropolitan Government - Seoul National University, Boramae Medical Center.

Compliance with Ethical Standards

Conflict of interest

There are no conflicts of interest to declare.

References

  1. 1.
    Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ (2010) Changing mortality in congenital heart disease. J Am Coll Cardiol 56(14):1149–1157CrossRefGoogle Scholar
  2. 2.
    Webb G, Mulder BJ, Aboulhosn J, Daniels CJ, Elizari MA, Hong G, Horlick E, Landzberg MJ, Marelli AJ, O’Donnell CP, Oechslin EN, Pearson DD, Pieper EP, Saxena A, Schwerzmann M, Stout KK, Warnes CA, Khairy P (2015) The care of adults with congenital heart disease across the globe: current assessment and future perspective: a position statement from the International Society for Adult Congenital Heart Disease (ISACHD). Int J Cardiol 195:326–333CrossRefGoogle Scholar
  3. 3.
    Diller GP, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Li W, Babu-Narayan S, Wort SJ, Dimopoulos K, Gatzoulis MA (2015) Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 132(22):2118–2125CrossRefGoogle Scholar
  4. 4.
    Engelings CC, Helm PC, Abdul-Khaliq H, Asfour B, Bauer UM, Baumgartner H, Kececioglu D, Korten MA, Diller GP, Tutarel O (2016) Cause of death in adults with congenital heart disease—an analysis of the German National Register for congenital heart defects. Int J Cardiol 211:31–36CrossRefGoogle Scholar
  5. 5.
    Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D34–D41CrossRefGoogle Scholar
  6. 6.
    Firth D (1993) Bias reduction of maximum likelihood estimates. Biometrika 80(1):27–38CrossRefGoogle Scholar
  7. 7.
    Kempny A, Dimopoulos K, Gatzoulis MA (2017) Declining incidence and prevalence of Eisenmenger syndrome in the developed world: a triumph of modern medicine. Heart 103(17):1313–1314CrossRefGoogle Scholar
  8. 8.
    Hjortshoj CS, Jensen AS, Sorensen K, Nagy E, Johansson B, Kronvall T, Dellborg M, Estensen ME, Holmstrom H, Turanlahti M, Thilen U, Sondergaard L (2017) Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977–2012. Heart 103(17):1353–1358CrossRefGoogle Scholar
  9. 9.
    Martin-Garcia AC, Arachchillage DR, Kempny A, Alonso-Gonzalez R, Martin-Garcia A, Uebing A, Swan L, Wort SJ, Price LC, McCabe C, Sanchez PL, Dimopoulos K, Gatzoulis MA (2018) Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome. Heart 104(1):45–50CrossRefGoogle Scholar
  10. 10.
    Sakazaki H, Niwa K, Nakazawa M, Saji T, Nakanishi T, Takamuro M, Ueno M, Kato H, Takatsuki S, Matsushima M, Kojima N, Ichida F, Kogaki S, Kido S, Arakaki Y, Waki K, Akagi T, Joo K, Muneuchi J, Suda K, Lee HJ, Shintaku H (2013) Clinical features of adult patients with Eisenmenger’s syndrome in Japan and Korea. Int J Cardiol 167(1):205–209CrossRefGoogle Scholar
  11. 11.
    Remkova A, Simkova I, Valkovicova T, Kaldararova M (2016) Platelet abnormalities in adults with severe pulmonary arterial hypertension related to congenital heart defects (Eisenmenger syndrome). Blood Coagul Fibrinolysis 27(8):925–929CrossRefGoogle Scholar
  12. 12.
    Lill MC, Perloff JK, Child JS (2006) Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol 98(2):254–258CrossRefGoogle Scholar
  13. 13.
    Sakazaki H, Niwa K, Echigo S, Akagi T, Nakazawa M (2007) Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease-Japanese multi-center study. Int J Cardiol 120(1):72–78CrossRefGoogle Scholar
  14. 14.
    Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JS, Gatzoulis MA (2006) Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 27(14):1737–1742CrossRefGoogle Scholar
  15. 15.
    Baskar S, Horne P, Fitzsimmons S, Khoury PR, Vettukattill J, Niwa K, Agaki T, Spence M, Sakazaki H, Veldtman G (2017) Arrhythmia burden and related outcomes in Eisenmenger syndrome. Congenit Heart Dis 12(4):512–519CrossRefGoogle Scholar
  16. 16.
    Kempny A, Hjortshoj CS, Gu H, Li W, Opotowsky AR, Landzberg MJ, Jensen AS, Sondergaard L, Estensen ME, Thilen U, Budts W, Mulder BJ, Blok I, Tomkiewicz-Pajak L, Szostek K, D’Alto M, Scognamiglio G, Prokselj K, Diller GP, Dimopoulos K, Wort SJ, Gatzoulis MA (2017) Predictors of death in contemporary adult patients with Eisenmenger syndrome: a multicenter study. Circulation 135(15):1432–1440CrossRefGoogle Scholar
  17. 17.
    Moore B, Yu C, Kotchetkova I, Cordina R, Celermajer DS (2018) Incidence and clinical characteristics of sudden cardiac death in adult congenital heart disease. Int J Cardiol 254:101–106CrossRefGoogle Scholar
  18. 18.
    Naidu P, Grigg L, Zentner D (2017) Mortality in adults with congenital heart disease. Int J Cardiol 245:125–130CrossRefGoogle Scholar
  19. 19.
    Niwa K, Perloff JK, Kaplan S, Child JS, Miner PD (1999) Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol 34(1):223–232CrossRefGoogle Scholar
  20. 20.
    Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, Stone S (1998) Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 19(12):1845–1855CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Hyo Soon An
    • 1
    • 2
  • Gi Beom Kim
    • 1
    Email author
  • Mi Kyoung Song
    • 1
  • Ji Seok Bang
    • 3
  • Sang Yun Lee
    • 1
  • Eun Jung Bae
    • 1
  • Chung Il Noh
    • 3
  1. 1.Department of Pediatrics, Seoul National University Children’s HospitalSeoul National University College of MedicineSeoulSouth Korea
  2. 2.Department of PediatricsSeoul Metropolitan Government - Seoul National University Boramae Medical CenterSeoulSouth Korea
  3. 3.Department of PediatricsSejong General HospitalBucheonSouth Korea

Personalised recommendations